Contrast media research

Investigative Radiology

Volumn 34, Issue 12, 1999, Pages 785-790

  Runge, Val M ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; MANGAFODIPIR;

ANGIOGRAPHY; ARTICLE; CHELATION; CONTRAST ENHANCEMENT; ECHOGRAPHY; LIVER SCINTISCANNING; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0032703701     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199912000-00009     Document Type: Article

References (102)

1. Yasuda R, Munechika H. Delayed adverse reactions to nonionic monomeric contrast-enhanced media. Invest Radiol 1998;33:1-5.
2. Deray G, Bagnis C, Jacquiaud C, et al. Renal effects of low and isoosmolar contrast media on renal hemodynamic in a normal and ischemic dog kidney. Invest Radiol 1999;34:1-4.
3. Drescher P, Knes JM, Madsen PO. Prevention of contrast medium-induced renal vasospasm by phosphodiesterase inhibition. Invest Radiol 1998;33:858-862.
4. Krause W. In vitro and animal experiments in contrast media testing. Invest Radiol 1998;33:182-191.
5. Mironidou M, Ximitidou O, Christopoulos S, Kokkas B. The effect of some iodinated contrast media on human plasma butyrylcholinesterase activity. Invest Radiol 1998;33:308-310.
6. Murphy ME, Tublin ME, Li S. Influence of contrast media on the response of rat renal arteries to endothelin and nitric oxide: Influence of contrast media. Invest Radiol 1998;33:356-365.
7. Wasaki M, Kawamura H, Sugimoto J, et al. Comparative toxic effects of iobitridol and iohexol on the kidney. Invest Radiol 1998;33:393-400.
8. Zwaan M, Von Helden J, Weiss HD. Local effect of three nonionic contrast media on the arterial blood flow velocity during iliofemoral arteriography. Invest Radiol 1999;34:5-12.
9. Duarte CG, Zhang J, Ellis S. Effects of radiocontrast and endothelin administration on systolic blood pressure and renal damage in male spontaneously hypertensive and Wistar Kyoto rats with phentolamine-induced adrenergic blockade. Invest Radiol 1998;33:104-112.
10. Duarte CG, Zhang J, Ellis S. Effects of radiocontrast, mannitol, and endothelin on blood pressure and renal damage in the aging male spontaneously hypertensive rat. Invest Radiol 1999;34:455-462.
11. La Noce A, Frigeni V, Demicheli F, et al. Neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia: EEG evaluation. Invest Radiol 1999;34:262-267.
12. Swan SK, Lambrecht LJ, Townsend R, et al. Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. Invest Radiol 1999;34:443-448.
13. Ueda J, Furukawa T, Yamamoto T, et al. Permeability of gadolinium-DTPA through two types of hemodialysis membrane. Invest Radiol 1998;33:734-737.
14. Jinkins JR, Williams RF, Xiong L. Evaluation of gadopentetate dimeglumine magnetic resonance cisternography in an animal model: Preliminary report. Invest Radiol 1999;34:156-159.
15. Brurok H, Berg K, Sneen L, et al. Cardiac metal contents after infusions of manganese. An experimental evaluation in the isolated rat heart. Invest Radiol 1999;34:470-476.
16. Kim SH, Chang KH, Chi JG, et al. Sequential change of MR signal intensity of the brain after manganese administration in rabbits. Correlation with manganese concentration and histopathologic findings. Invest Radiol 1999;34:383-393.
17. Adzamli K, Periasamy MP, Spiller M, Koenig SH. NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA). a nonionic MRI agent. Invest Radiol 1999;34:410-414.
18. Kellar KE, Fossheim SL, Koenig SH. Magnetic field dependence of solvent proton relaxation by solute dysprosium (III) complexes. Invest Radiol 1998;33:835-840.
19. Koenig SH. Solvent relaxation by uniformly magnetized solute spheres. The classical-quantal connection. Invest Radiol 1998;33: 822-827.
20. Vander Elst L, Laurent S, Muller RN. Multinuclear magnetic resonance characterization of paramagnetic contrast agents. The manifold effects of concentration and counterions. Invest Radiol 1998; 33:828-834.
21. Bulte JW, Wu C, Brechbiel MW, et al. Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometry. Invest Radiol 1998;33:841-845.
22. Fossheim SL, Spiller M, Kellar KE. NMRD investigation of DyDTPA-and GdDTPA-labeled starch particles. Selection of a suitable suspension medium and influence of the starch matrix on relaxivity. Invest Radiol 1999;34:287-295.
23. Curtet C, Maton F, Havet T, et al. Polylysine-Gd-DTPAn and polylysine-Gd-DOTAn coupled to anti-CEA F(ab')2 fragments as potential immunocontrast agents. Relaxometry, biodistribution, and magnetic resonance imaging in nude mice grafted with human colorectal carcinoma. Invest Radiol 1998;33:752-761.
24. Ranganathan RS, Fernandez ME, Kang SI, et al. New multimeric magnetic resonance imaging agents. Invest Radiol 1998;33:779-797.
25. Fossheim SL, Colet JM, Mansson S, et al. Paramagnetic liposomes as magnetic resonance imaging contrast agents. Assessment of contrast efficacy in various liver models. Invest Radiol 1998;33:810-821.
26. Grunder W, Biesold M, Wagner M, Werner A. Improved nuclear magnetic resonance microscopic visualization of joint cartilage using liposome entrapped contrast agents. Invest Radiol 1998;33: 193-202.
27. Hofmann B, Fischer CO, Lawaczeck R, et al. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent gadobutrol. Invest Radiol 1999;34:126-133.
28. Danek AN, Bryant RG. Magnetic relaxation contrast agents in magnetization transfer imaging. Invest Radiol 1998;33:773-778.
29. Petersein J, Franke B, Fouillet X, Hamm B. Evaluation of liposomal contrast agents for liver CT in healthy rabbits. Invest Radiol 1999; 34:401-409.
30. Haggag KJ, Russell D, Walday P, et al. Air-filled ultrasound contrast agents do not damage the cerebral microvasculature or brain tissue in rats. Invest Radiol 1998;33:129-135.
31. Fowlkes JB, Sirkin DW, Ivey JA, et al. Transcutaneous interruption of ultrasound contrast agents for blood flow evaluation. Invest Radiol 1998;33:893-901.
32. Klibanov AL, Ferrara KW, Hughes MS, et al. Direct video-microscopic observation of the dynamic effects of medical ultrasound on ultrasound contrast microspheres. Invest Radiol 1998;33:863-870.
33. Sontum PC, Ostensen J, Dyrstad K, Hoff L. Acoustic properties of NC100100 and their relation with the microbubble size distribution. Invest Radiol 1999;34:268-275.
34. Wible J, Jr., Wojdyla J, Bugaj J, Brandenburger G. Effects of inhaled gases on the ultrasound contrast produced by microspheres containing air or perfluoropropane in anesthetized dogs. Invest Radiol 1998;33:871-879.
35. Unger EC, McCreery TP, Sweitzer RH, et al. Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent. Invest Radiol 1998;33:886-892.
36. Wu Y, Unger EC, McCreery TP, et al. Binding and lysing of blood clots using MRX-408. Invest Radiol 1998;33:880-885.
37. Lenihan DJ, McGoron AJ, Gabel M. et al. Reliability of technetium-99m Q12 and thallium-201 myocardial activity measurements after triphenyl tetrazolium chloride myocardial staining by perfusion. Invest Radiol 1999;34:276-281.
38. Rosenbaum AF, McGoron AJ, Millard RW, et al. Uptake of seven myocardial tracers during increased myocardial blood flow by dobutamine infusion. Invest Radiol 1999;34:91-98.
39. Baum RP, Brummendorf TH. Radioimmunolocalization of primary and metastatic breast cancer. Q J Nucl Med 1998;42:33-42.
40. Maloney DG, Donovan K, Hamblin TJ. Antibody therapy for treatment of multiple myeloma. Semin Hematol 1999;36(1 Suppl 3): 30-33.
41. Krenning EP, de Jong M, Kooij PP, et al. Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy. Ann Oncol 1999;10(Suppl 2):S23-S29.
42. Procaccini E, Chianelli M, Pantano P, Signore A. Imaging of autoimmune diseases. Q J Nucl Med 1999;43:100-112.
43. Noto RB, Scheiner JD. Advances in nuclear medicine: Current concepts. Med Health R I 1999;82:190-194.
44. Seregni E, Chiti A, Bombardieri E. Radionuclide imaging of neuroendocrine tumours: Biological basis and diagnostic results. Eur J Nucl Med 1998;25:639-658.
45. Dedieu V, Finat-Duclos F, Renou JP, et al. In vivo tissue extracellular volume fraction measurement by dynamic spin-lattice MRI relaxometry: Application to the characterization of muscle fiber types. Invest Radiol 1999;34:185-189.
46. Dupas B, Bach-Gansmo T, Meflah K, Muller RN. Synergistic effects of relaxation and susceptibility in differentiation between compartmentalized and noncompartmentalized tissues. Invest Radiol 1998; 33:268-272.
47. Aso H, Takeda K, Ito T, et al. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol 1998;33:22-32.
48. Geschwind JF, Saeed M, Wendland MF, Higgins CB. Depiction of reperfused myocardial infarction using contrast-enhanced spin echo and gradient echo magnetic resonance imaging. Invest Radiol 1998; 33:386-392.
49. Runge VM. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model. Invest Radiol 1998;33:263-267.
50. Runge VM, Williams NM. Dynamic contrast-enhanced magnetic resonance imaging in a model of splenic metastasis. Invest Radiol 1998;33:45-50.
51. Runge VM, Williams NM, Lee C, Timoney JF. Magnetic resonance imaging in a spinal abscess model. Preliminary report. Invest Radiol 1998;33:246-255.
52. Axmann C, Bohndorf K, Gellissen J, et al. Mechanisms of accumulation of small particles of iron oxide in experimentally induced osteosarcomas of rats: A correlation of magnetic resonance imaging and histology. Preliminary results. Invest Radiol 1998;33:236-245.
53. Fallis S, Beaty-Nosco J, Dorshow RB, Adzamli K. Polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as a potential contrast agent for magnetic resonance imaging: Particle stability in biologic fluids. Invest Radiol 1998;33:847-852.
54. Frank H, Loewe R, Loewe C, et al. Efficacy of thrombolytic therapy in pulmonary embolism determined by MION-enhanced MRA: An experimental study in rabbits. Invest Radiol 1998;33:853-857.
55. Knollmann FD, Bock JC, Rautenberg K, et al. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study. Invest Radiol 1998;33:637-643.
56. Berchtenbreiter C, Bruening R, Wu RH, et al. Comparison of the diagnostic information in relative cerebral blood volume, maximum concentration, and subtraction signal intensity maps based on magnetic resonance imaging of gliomas. Invest Radiol 1999; 34:75-81.
57. Tynninen O, Aronen HJ, Ruhala M, et al. MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation. Invest Radiol 1999;34:427-434.
58. Jung G, Krahe T, Kugel H, et al. Detection of focal hepatic lesions: Effects of superparamagnetic iron oxide (AMI-25) on magnetic resonance imaging of the liver using T2-weighted fast spin-echo sequences and gradient-and-spin-echo sequences at 1.0 tesla. Invest Radiol 1998;33:61-67.
59. Dromigny-Badin A, Zhu YM, Magnin I, Revel D. Fusion of cine magnetic resonance and contrast-enhanced first-pass magnetic resonance data in patients with coronary artery disease: A feasibility study. Invest Radiol 1998;33:12-21.
60. Kirchin MA, Pirovano GP, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol 1998;33:798-809.
61. Goudemant JF, Van Beers BE, Demeure R, et al. Comparison of unenhanced and gadoxetate disodium-enhanced spin-echo magnetic resonance imaging for the detection of experimental hepatocellular carcinoma in the rat. Invest Radiol 1998;33:80-84.
62. Marti-Bonmati L, Lonjedo E, Poyatos C, Casillas C. MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers. Invest Radiol 1998;33:717-722.
63. Flamm CR. Technology assessment of magnetic resonance angiography. Why pretty pictures are not enough: An overview. Invest Radiol 1998;33:547-552.
64. Swan JS, Langlotz CP. Patient preference for magnetic resonance versus conventional angiography. Assessment methods and implications for cost-effectiveness analysis: An overview. Invest Radiol 1998;33:553-559.
65. Leclerc X, Gauvrit JY, Nicol L, et al. Gadolinium-enhanced fast three-dimensional angiography of the neck: Technical aspect. Invest Radiol 1999;34:204-210.
66. Steffens JC, Link J, Heller M. Contrast-enhanced magnetic resonance angiography of the cervical arteries. Invest Radiol 1998;33:573-577.
67. Krinsky G. Gadolinium-enhanced three-dimensional magnetic resonance angiography of the thoracic aorta and arch vessels. Invest Radiol 1998;33:587-605.
68. Yamada CY, Grygotis LA, Kaufman J. Gadolinium-enhanced magnetic resonance angiography of the aorta. Invest Radiol 1998;33: 618-627.
69. Carlos RC, Prince MR, Ward JS, et al. Renal anatomic changes on magnetic resonance imaging and gadolinium-enhanced magnetic resonance angiography after renal revascularization. Invest Radiol 1998;33:660-669.
70. Hany TF, Leung DA, Pfammatter T, Debatin JF. Contrast-enhanced magnetic resonance angiography of the renal arteries. Invest Radiol 1998;33:653-659.
71. Schoenberg SO, Knopp MV, Prince MR, et al. Arterial-phase three-dimensional gadolinium magnetic resonance angiography of the renal arteries. Strategies for timing and contrast media injection. Invest Radiol 1998;33:506-514.
72. Tello R, Thomson KR, Witte D, et al. Dynamic gadolinium DTPA-enhanced magnetic resonance of intravascular stents. Invest Radiol 1998;33:411-414.
73. Boos M, Lentschig M, Scheffler K, et al. Contrast-enhanced magnetic resonance angiography of peripheral vessels. Different contrast agent applications and sequence strategies. Invest Radiol 1998;33: 538-546.
74. Lee VS, Lee HM, Rofsky NM. Magnetic resonance angiography of the hand. Invest Radiol 1998;33:687-698.
75. Kauczor HU. Contrast-enhanced magnetic resonance angiography of the pulmonary vasculature. Invest Radiol 1998;33:606-617.
76. Stafford-Johnson DB, Chenevert TL, Cho KJ, Prince MR. Portal venous magnetic resonance angiography. Invest Radiol 1998;33: 628-636.
77. Wilson MW, Hamilton BH, Dong Q, et al. Gadolinium-enhanced magnetic resonance venography of the portal venous system prior to transjugular intrahepatic portosystemic shunts and liver transplantation. Invest Radiol 1998;33:644-652.
78. Hany TF, Schmidt M, Schoenenberger AW, Debatin JF. Contrast-enhanced three-dimensional magnetic resonance angiography of the splanchnic vasculature before and after caloric stimulation. Invest Radiol 1998;33:682-686.
79. Heiss SG, Li KC. Magnetic resonance angiography of mesenteric arteries. Invest Radiol 1998;33:670-681.
80. Parker DL, Tsuruda JS, Goodrich KC, et al. Contrast-enhanced magnetic resonance angiography of cerebral arteries. Invest Radiol 1998;33:560-572.
81. Ho VB, Foo TK. Optimization of gadolinium-enhanced magnetic resonance angiography using an automated bolus-detection algorithm (MR SmartPrep). Invest Radiol 1998;33:515-523.
82. Maki JH, Prince MR, Chenevert TC. Optimizing three-dimensional gadolinium-enhanced magnetic resonance angiography. Invest Radiol 1998;33:528-537.
83. Mistretta CA, Grist TM. X-ray digital subtraction angiography to magnetic resonance-digital subtraction angiography using three-dimensional TRICKS. Historical perspective and computer simulations. Invest Radiol 1998;33:496-505.
84. Saloner D. Determinants of image appearance in contrast-enhanced magnetic resonance angiography. Invest Radiol 1998;33:488-495.
85. Schild HH, Kuhl CK. Contrast-enhanced magnetic resonance angiography. Potential applications and pitfalls in magnetic resonance angiography-guided therapy. Invest Radiol 1998;33:524-527.
86. Li D, Zheng J, Bae KT, et al. Contrast-enhanced magnetic resonance imaging of the coronary arteries. Invest Radiol 1998;33:578-586.
87. Dong Q, Hurst DR, Weinmann HJ, et al. Magnetic resonance angiography with gadomer-17. An animal study. Invest Radiol 1998;33: 699-708.
88. Muhler A. The future of contrast-enhanced magnetic resonance angiography. Are blood pool agents needed? Invest Radiol 1998;33: 709-714.
89. Fischbach R, Landwehr P, Svaland M. et al. Spiral CT angiography of the abdominal aorta. Comparison of iodixanol and ioversol. Invest Radiol 1999;34:374-380.
90. Lopez Hanninen E, Vogl TJ, Bechstein WO, et al. Biphasic spiral computed tomography for detection of hepatocellular carcinoma before resection or orthotopic liver transplantation. Invest Radiol 1998;33:216-221.
91. Vogl TJ, Hanninen EL, Bechstein WO, et al. Biphasic spiral computed tomography versus digital subtraction angiography for evaluation of arterial thrombosis after orthotopic liver transplantation. Invest Radiol 1998;33:136-140.
92. Schmermund A, Gerber T, Behrenbeck T, et al. Measurement of myocardial infarct size by electron beam computed tomography: A comparison with 99mTc sestamibi. Invest Radiol 1998;33:313-321.
93. Schroeder RJ, Maeurer J, Vogl TJ, et al. D-galactose-based signal-enhanced color Doppler sonography of breast tumors and tumorlike lesions. Invest Radiol 1999;34:109-115.
94. Willam C, Maurer J, Schroeder R, et al. Assessment of vascularity in reactive lymph nodes by means of D-galactose contrast-enhanced Doppler sonography. Invest Radiol 1998;33:146-152.
95. Uggowitzer MM, Kugler C, Mischinger HJ, et al. Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver. J Ultrasound Med 1999;18:445-451;quiz, 453-454.
96. Main ML, Grayburn PA. Clinical applications of transpulmonary contrast echocardiography. Am Heart J 1999;137:144-153.
97. Lev-Toaff AS, Langer JE, Rubin DL, et al. Safety and efficacy of a new oral contrast agent for sonography: A phase II trial. Am J Roentgenol 1999;173:431-436.
98. Song K, Cho D, Shinn K, et al. Gas dynamics in CO2 angiography: In vitro evaluation in a circulatory system model. Invest Radiol 1999; 34:151-155.
99. Kaufman JA, Geller SC, Bazari H, Waltman AC. Gadolinium-based contrast agents as an alternative at vena cavography in patients with renal insufficiency - early experience. Radiology 1999;212:280-284.
100. Spinosa DJ, Matsumoto AH, Angle JF, et al. Renal insufficiency: Usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous treatment. Radiology 1999;210:663-672.
101. Hammer FD, Goffette PP, Malaise J, Mathurin P. Gadolinium dimeglumine: An alternative contrast agent for digital subtraction angiography. Eur Radiol 1999;9:128-136.
102. Murphy KJ, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: A review of 36 cases. Am J Roentgenol 1996;167:847-849.